With early detection of prostate cancer recognised as a critical part in reducing the disease’s mortality rate, PanGIA ...

Johnson & Johnson has reported data from a Phase I trial of pasritamig for metastatic castration-resistant prostate cancer ...

Scientists say they have worked out a machine learning method with the ability to provide close to precise survival estimates of patients afflicted ...

In this pilot trial, acupuncture produced greater reductions in nocturia (waking up 1 or more times to urinate) relative to ...

For the local Prostate Cancer Support Group, which this year is celebrating its 25th Silver Anniversary, Biden’s diagnosis ...

Dr. Cheryl Matter shares expert insights into the role physician education can play in ensuring innovative tools reach patients and help improve patient care.

Dr Yuksel Ürün praised the CheckMate214 trial’s nivolumab-ipilimumab combo for “superior overall survival ... and future of prostate cancer care. Tapping into real-time insights allows ...

(UroToday.com) The 2025 ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Rana McKay discussing the molecular and clinical characterization of KLK2 mRNA expression in ...

Foresight Diagnostics, a leading diagnostics company specializing in ultra-sensitive minimal residual disease (MRD) detection, today announced a strategic, worldwide partnership with QIAGEN to develop ...

Nearly 4,000 participants came together on May 31 for We Walk UHNITED presented by Rogers, UHN Foundation's newest ...

Auron has dosed the first subject in the Phase I trial of AUTX-703, targeting individuals with advanced haematologic ...